From Medscape Gastroenterology

Medscape Medical News from

The Liver Meeting 2015: American Association for the Study of Liver Diseases (AASLD)

November 13 - 17, 2015; San Francisco, California

Conference News

AASLD Sofosbuvir, Velpatasvir Promising in Several Hep C Genotypes
Medscape Medical News, November 20, 2015
AASLD Daclatasvir, Sofosbuvir, Ribavirin Effective in Hep C Type 3
Medscape Medical News, November 19, 2015
AASLD Medicaid Denial for Hep C Drugs Nearing 50% in Some States
Medscape Medical News, November 18, 2015
AASLD New Treatments Not Enough to Eliminate Hepatitis C
Medscape Medical News, November 17, 2015

AASLD Viekira Pak Results Reassuring for Compensated Cirrhosis
Medscape Medical News, November 16, 2015
AASLD Obeticholic Acid Promising for Biliary Cholangitis Long-term
Medscape Medical News, November 15, 2015
AASLD Hepatitis C Still Focus of Liver Meeting
Medscape Medical News, November 6, 2015

Medscape Gastroenterology© WebMD, LLC

Expert Commentary

New Data May Soon Reshape Transplantation Decisions in ESLD
William F. Balistreri, MD
Progress Noted in Treatment of Several Common Liver Diseases
William F. Balistreri, MD
Surveying the Latest Data in Fatty Liver Disease
William F. Balistreri, MD
Hepatitis B Takes Center Stage
William F. Balistreri, MD
A Focus on Hepatitis C: Outcomes
William F. Balistreri, MD
A Focus on Hepatitis C: Novel Therapeutic Regimens
William F. Balistreri, MD
A Focus on Hepatitis C: Cascade of Care
William F. Balistreri, MD

Previous Coverage

All material on this website is protected by copyright, Copyright © 1994-2019 by WebMD LLC. This website also contains material copyrighted by 3rd parties.